Home

Overview

Strategy

Intelligence

Publications

Training

Meetings

Slide Presentations

Contact Us

Cardiovascular Biomarkers and Surrogate Endpoints Symposium
Bethesda, Maryland
August 1-2, 2003

As a service to our meeting attendees, the following presentation materials are available for viewing. Please note that material availability is at the discretion of our participating faculty.

1. Historical Perspective - Dr. Therese Heinonen
2. Need for Biomarkers in Drug Development - Dr. Donald Black
3. Basic Mechanisms to Biomarkers - Dr. Peter Libby
4. Genetics of CAD - Dr. Daniel Gaudet
5. Impact of Genomics on CAD Breakthroughs - Dr. Jamie Engert
6. Angiography - Dr. David Waters
7. Carotid IMT - Dr. Daniel O'Leary
8. Intravascular Ultrasound - Dr. Jean-Claude Tardif
9. Electron Beam CT Coronary Calcium as a Surrogate - Dr. Pamela Ouyang
10. The Case for Imaging Endpoints in Drug Approval - Dr. Steven Nissen
    (Please contact Dr. Nissen directly at nissens@ccf.org for slide requests)
    
11. A Regulatory Perspective - Dr. David Orloff
12. An NIH Perspective - Dr. Elizabeth Nabel
13. Overview of Lipids and Lipoproteins - Dr. David Waters
14. New Targets and Populations at Risk - Dr. Donald Black
15. Apolipoprotein-Defined Lipoproteins - Dr. Petar Alaupovic
16. Lipoprotein Particle Subclasses - Dr. James Otvos
17. Oxidative Stress 1 - Dr. Jean-Claude Tardif
18. Oxidative Stress 2 - Dr. Sam Tsimikas
19. Endothelial Function - Dr. John Deanfield
20. Cardiac PET - Dr. Marcelo Di Carli
21. Novel Technologies - Dr. Peter Libby
22. Vascular MR and Spiral CT - Dr. Zahi Fayad